LXRX
Lexicon Pharmaceuticals
$1.49
+$0.01 (+0.34%)Oct 28, 2026
Key metrics
The numbers that frame LXRX today
- Market cap
- $660.76M
- Gross margin
- 99.1%
- EV / Sales
- 16.2
- ROIC
- -33.7%
- Div yield
- 0%
- Debt / equity
- 0.3
- 52wk Low
- $1.10
- 52wk High
- $2.68
Growth
Revenue and earnings trend for LXRX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about LXRX
Is Lexicon Pharmaceuticals a good buy?
Hold. Lexicon Pharmaceuticals has excellent momentum, but poor quality makes the setup mixed. Growth looks weak. That could put pressure on the long-term business case. We think Lexicon Pharmaceuticals is selling at a very high price.
What is the market capitalization of LXRX?
Lexicon Pharmaceuticals's market capitalization is $660.76M.
What is the 52-week high for LXRX stock?
The 52-week high for Lexicon Pharmaceuticals is $2.68. The current close of $1.49 is 44.6% below that high.
What is the 52-week low for LXRX stock?
The 52-week low for Lexicon Pharmaceuticals is $1.10. The current close of $1.49 is 35% above that low.
Does LXRX stock pay dividends?
Lexicon Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for LXRX?
Lexicon Pharmaceuticals's Debt / Equity ratio is 0.3.